{"id":21994,"date":"2026-06-17T00:00:00","date_gmt":"2026-06-16T22:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=cafece2fab4813251b1d8ee1e18ba665"},"modified":"2026-06-17T00:00:00","modified_gmt":"2026-06-16T22:00:00","slug":"everlab-raises-au65m-series-a-to-make-world-class-preventative-healthcare-something-everyone-can-access","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=21994","title":{"rendered":"Everlab Raises AU$65m Series A to Make World-Class Preventative Healthcare Something Everyone Can Access"},"content":{"rendered":"

MELBOURNE, Australia--(BUSINESS WIRE)--Australian healthtech Everlab<\/b><\/a> has raised AU$65m in Series A funding. The oversubscribed round was led by Airtree Ventures<\/a> (AU), with participation from global investors including Plural<\/a> (EU) and existing investors Left Lane Capital<\/a> (US) and b2venture<\/a> (EU), alongside angel investors including Australian Test captain Pat Cummins.<\/p><\/a><\/a><\/a><\/a>

\nThe round marks Everlab\u2019s evolution into a complete care platform, transforming the primary care system built to treat illness into one built to prevent it. Today, patients navigate fragmented point solutions that don't connect: legacy providers whose records live in isolation, transactional telehealth appointments with no continuity, and wearables that produce surface-level insights without clinical follow-through.<\/p>

\nEverlab\u2019s digital app organizes diagnostics, doctors, specialists, prescriptions and continuous AI care in one place, giving patients a longitudinal view of their health for the first time. The platform integrates with 1,850+ health provider locations, 180+ active clinicians and 30+ wearable devices, and processes more than 200,000 health reports per month.<\/p>

\n\u201cThe existing system is fragmented, handing patients between providers and hoping the information follows,\u201d says Marc Hermann, Co-founder and CEO of Everlab. \u201cWe built Everlab to hold the full picture, surface health blind spots and coordinate what needs to happen next\u2014from targeted screenings to personalized health plans\u2014helping more people live longer, healthier lives.\u201d<\/p>

\nFounded in Melbourne in 2023, Everlab has completed 40,000+ consultations supporting 20,000 individual patients and major corporate partners, including Boston Consulting Group, BHP and Bain & Company. Having processed over 21 million biomarker test results, more than 25% of members have had findings flagged that have not been identified through the existing healthcare system.<\/p>

\n\u201cOur patient base reflects the broader Australian population, and earning their trust to hold decades of their health data is the foundation everything else runs on,\u201d says Dr Steven Lu, the company\u2019s Chief Medical Officer. \u201cOur goal is to cut a new path for primary care globally, proving that deep patient engagement and first-class preventative care don\u2019t just improve outcomes, it reduces the lifetime cost of care for everyone.\u201d<\/p>

\nThe raise marks Everlab\u2019s move into the $10 trillion global consumer healthcare market, starting with the UK. The funding will be used to strengthen its clinical and technology infrastructure and accelerate its global rollout.<\/p>

\n\u201cThe more time we spent with the Everlab team, the more convinced we became that they\u2019re building a generational health business. With a world-class product and growing at a pace we rarely see, they\u2019re already the leader in Australia and we\u2019re backing them to do the same globally,\u201d says John Henderson, Partner at Airtree.<\/p>

\nCarina Namih, Partner at Plural, added: \u201cEvery company that has tried to own the patient journey has ended up either selling doctor time by the minute or reselling lab tests with thin margins. Everlab is building the layer above both: the system that interprets and coordinates your health data over time rather than capturing a single transaction. The fact that they\u2019ve already proven their model operationally in Australia, at scale, is what convinced me this is the version that genuinely works.\u201d<\/p>

\nAbout Everlab<\/b><\/p>

\nEverlab is a healthtech company providing preventative, personalized healthcare through a data-driven and AI-enabled model. By combining advanced diagnostics, clinician-led care and technology, Everlab helps detect and prevent disease risk earlier.<\/p>

\nFounded in Melbourne in 2023, Everlab operates across Australia and New Zealand, supporting both individuals and organizations through preventative healthcare programs.<\/p>

\nEverlab\u2019s mission is to maximize healthspan at the lowest lifetime cost, empowering people to live their richest and most meaningful lives. For more information, visit www.everlab.com.au<\/a>.<\/p> Contacts<\/b>

\nMedia enquiries:<\/b>Keira Shanley\nJack Taylor PR\neverlab@jacktaylorpr.com<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"

MELBOURNE, Australia–(BUSINESS WIRE)–Australian healthtech Everlab has raised AU$65m in Series A funding. The oversubscribed round was led by Airtree Ventures (AU), with participation from global investors including Plural (EU) and existing investors…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-21994","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/21994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21994"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/21994\/revisions"}],"predecessor-version":[{"id":21995,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/21994\/revisions\/21995"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}